Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation

Endoscopy

Volumn 36, Issue 6, 2004, Pages 535-542

  Arvanitakis, M ^a   Van Laethem, J L ^a   Parma, J ^a   De Maertelaer, V ^b   Delhaye, M ^a   Deviere J ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CA 19-9 ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; GENOTYPE; HUMAN; IMAGING SYSTEM; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PANCREAS CALCIFICATION; PANCREAS CANCER; PANCREAS DUCT; PANCREAS FUNCTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 3042558512     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814401     Document Type: Article

References (37)

1. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987; 60: 2284-2303
2. Ahmad NA, Lewis JD, Ginsberg GG et al. Long-term survival after pancreatic resection for pancreatic carcinoma. Am J Gastroenterol 2001; 96: 2609-2615
3. Lowenfels AB, Maisonneuve P, Cavallini G et al. and the international Pancreatitis Study Group. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328: 1433-1437
4. Malka D, Hammel P, Maire F et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002; 51: 849-852
5. McGrath JP, Capon DJ, Smith DH et al. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature 1983; 304: 501-506
6. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein-kinase signaling pathways. Curr Opin Cell Biol 1999; 11: 211-218
7. Almoguera C, Shibata D, Forrester K et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-554
8. Kondo H, Sugano K, Fukayama N et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994; 73: 1589-1594
9. Nakamura Y, Onda M, Uchida E. Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma. Pancreas 1999; 18: 133-140
10. Van Laethem JL, Vertongen P, Deviere J et al. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumors. Gut 1995; 36: 781-787
11. Cerny WL, Mangold KA, Scarpelli DG. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 1992; 52: 4507-4513
12. Tada M, Ohashi M, Shiratori Y et al. Analysis of K-ras gene mutation in hyperplasic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996; 110: 227-231
13. Lüttges J, Schlehe B, Menke MA et al. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplasic, and metaplasic ductal epithelium. Cancer 1999; 85: 1703-1710
14. Banerjee S, Zoubine MN, Mullick M et al. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations. Pancreas 2000; 20: 248-255
15. Moore PS, Sipos B, Orlandini S et al. Genetic profile of 22 pancreatic carcinoma cell lines: analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 2001; 439: 798-802
16. Furuya N, Kawa S, Akamatsu T, Furihata K. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 1997; 113: 593-598
17. Boadas J, Mora J, Urgell E et al. Clinical usefulness of K-ras mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Eur J Gastroenterol Hepatol 2001; 13: 1153-1159
18. Löhr M, Müller P, Mora J et al. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Gastrointest Endosc 2001; 53: 734-743
19. Van Laethem JL, Bourgeois V, Parma J et al. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc 1998; 47: 479-485
20. Queneau PE, Adessi GL, Thibault P et al. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice. Am J Gastroenterol 2001; 96: 700-704
21. Barthelemy P, Bouisson M, Escourou J et al. Identification of K-ras mutation in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995; 123: 188-191
22. Einarsson K, Bjökhem I, Eklöf R, Blomstrand R. 14C triolein breath test as a rapid and convenient screening test for fat malabsorption. Scand J Gastroenterol 1983; 18: 9-12
23. Cremer M. Les pancreatiques chroniques primitives. Acta Gastroenterol Belg 1976; 39: 522-546
24. Axon AT, Classen M, Cotton PB et al. Pancreatography in chronic pancreatitis: international definition. Gut 1984; 25: 1107-1112
25. Telford JJ, Farrell JJ, Saltzman JR et al. Pancreatic stent placement for duct disruption. Gastrointest Endosc 2002; 56: 18-24
26. Jiang W, Kahn SM, Guillem JG et al. Rapid detection of ras oncogenes in human tumors: application to colon, esophageal, and gastric cancer. Oncogene 1989; 4: 923-928
27. Verlaan-de Vries M, Bogaard ME, van den Elst H et al. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 1986; 50: 313-320
28. Löhr M, Maisonneuve P, Lowenfels AB. K-ras mutations and benign pancreatic disease. Int J Pancreatol 2000; 27: 93-103
29. Gansauge S, Schmidt RM, Muller J et al. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg 1998; 85: 337-340
30. Behn M, Qun S, Pankow W et al. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique. Clin Cancer Res 1998; 4: 361-371
31. Van Laethem JL. Ki-ras oncogene mutations in chronic pancreatitis: which have discriminating ability for malignant potential. Ann NY Acad Sci 1999; 880: 210-218
32. Hruban RH, Adsay NV, Albores-Saavedra J et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Path 2001; 25: 579-586
33. Apple SK, Hecht JR, Lewin DN et al. Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. Hum Pathol 1999; 30: 123-129
34. Layer P, Yamamoto H, Kalthoff L et al. The different courses of early-and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481-1487
35. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification and new genetic developments. Gastroenterology 2001; 120: 682-707
36. Biankin AV, Kench JG, Morey AL et al. Overexpression of p21 (WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 2001; 61: 8830-8837
37. Costentin L, Pages P, Bouisson M et al. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic disease. Pancreatology 2002; 2: 17-25